Detalles de la búsqueda
1.
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study.
Cancer
; 122(9): 1434-43, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26970343
2.
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.
Invest New Drugs
; 34(1): 119-28, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26643663
Resultados
1 -
2
de 2
1
Próxima >
>>